Klaus H Kahl
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database
Kroeze S, Eckert F, Lohaus F, Sackerer I, Skazikis G, Geier M, Szuecs M, Glatzer M, Schymalla M, Adebahr S, Verhoeff J, Siva S, Roeder F, Kahl K, Blanck O, Kaul D, Fritz C, Schaule J, Guckenberger M. Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database. Radiat Oncol 2021; 16:4.
06.01.2021Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database
06.01.2021Radiat Oncol 2021; 16:4
Kroeze Stephanie G C, Eckert Franziska, Lohaus Fabian, Sackerer Irina, Skazikis Georgios, Geier Michael, Szuecs Marcella, Glatzer Markus, Schymalla Markus M, Adebahr Sonja, Verhoeff Joost J C, Siva Shankar, Roeder Falk, Kahl Klaus H, Blanck Oliver, Kaul David, Fritz Corinna, Schaule Jana, Guckenberger Matthias
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Schaule J, Lohaus F, Abbasi-Senger N, Henke G, Szuecs M, Geier M, Sundahl N, Buergy D, Dummer R, Eckert F, Adebahr S, Schymalla M, Kroeze S, Blanck O, Stera S, Kahl K, Roeder F, Combs S, Kaul D, Claes A, Guckenberger M. Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score. Radiat Oncol 2020; 15:280.
14.12.2020Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
14.12.2020Radiat Oncol 2020; 15:280
Schaule Jana, Lohaus Fabian, Abbasi-Senger Nasrin, Henke Guido, Szuecs Marcella, Geier Michael, Sundahl Nora, Buergy Daniel, Dummer Reinhard, Eckert Franziska, Adebahr Sonja, Schymalla Markus M, Kroeze Stephanie G C, Blanck Oliver, Stera Susanne, Kahl Klaus H, Roeder Falk, Combs Stephanie E, Kaul David, Claes An, Guckenberger Matthias
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Schaule J, Lohaus F, Abbasi-Senger N, Henke G, Szuecs M, Geier M, Sundahl N, Buergy D, Dummer R, Eckert F, Adebahr S, Schymalla M, Kroeze S, Blanck O, Stera S, Kahl K, Roeder F, Combs S, Kaul D, Claes A, Guckenberger M. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score. Radiat Oncol 2020; 15:135.
01.06.2020Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
01.06.2020Radiat Oncol 2020; 15:135
Schaule Jana, Lohaus Fabian, Abbasi-Senger Nasrin, Henke Guido, Szuecs Marcella, Geier Michael, Sundahl Nora, Buergy Daniel, Dummer Reinhard, Eckert Franziska, Adebahr Sonja, Schymalla Markus M, Kroeze Stephanie G C, Blanck Oliver, Stera Susanne, Kahl Klaus H, Roeder Falk, Combs Stephanie E, Kaul David, Claes An, Guckenberger Matthias